Molecular Diagnostics Market
Molecular Diagnostics Market Size Share Companies & Trends Analysis Report By Test Type (PoC Tests, Lab Tests, Self-Test/ Over the Counter), By Technology (In Situ Hybridization, Sequencing, Chips & Microarrays, PCR, Mass Spectrometry (MS), INAAT, TMA, Others), By Product (Reagents, Instruments, Kits, Software & Services), By Application (Infectious Disease, Human Leukocyte Antigen Typing, Oncology, Microbiology, Pharmacogenomics, Genetic Testing, Neurological Disease, Cardiovascular Disease), By End-User (Hospital, Reference Labortories, Specialty Clinics), Based On Region And Segment Forecasts 2022 - 2028
- Product Id: BMRC 1516
- Pages: 300
- Publish Date: Apr-2023
- Category: Biotechnology
Fill Details
Verify Email
Check your inbox for Sample + Methodology
Note: For delivery of sample pages you must have a Domain Specific EmailID, normally your business email address complies. Generic Email IDs such as AOL, Hotmail, Yahoo, Gmail, MSNetc are not accepted
Segments
By Test Type
- PoC Tests
- Lab Tests
- Self-Test/ Over the Counter
By Technology
- In Situ Hybridization
- Sequencing
- Chips & Microarrays
-
PCR Type
- Multiplex PCR
- Other PCR
- Mass Spectrometry (MS)
- INAAT
- TMA
- Others
By Product
- Reagents
- Instruments
- Kits
- Software & Services
By Application
-
Infectious Disease
- Methicillin-resistant Staphylococcus Aureus (MRSA)
- Clostridium Difficile
- Vancomycin-resistant Enterococci (VRE)
- Carbapenem-resistant Bacteria
- Flu
- Respiratory Syncytial Virus (RSV)
- Candida
- Tuberculosis and Drug-resistant TBA
- Meningitis
- Gastrointestinal Panel Testing
- Chlamydia
- Gonorrhea
- HIV
- Hepatitis C
- Hepatitis B
- Other Infectious Disease
- Human Leukocyte Antigen Typing
-
Oncology
- Breast Cancer
- Prostate Cancer
- Colorectal Cancer
- Cervical Cancer
- Kidney Cancer
- Liver Cancer
- Blood Cancer
- Lung Cancer
- Other Cancer
- Microbiology
- Pharmacogenomics
-
Genetic Testing
- Newborn Screening
- Predictive and Presymptomatic Testing
- Other Genetic Testing
- Neurological Disease
- Cardiovascular Disease
By End User
- Hospital
- Reference Labortories
- Specialty Clinics
Regions and Country
North America
- U.S.
- Canada
Europe
- Germany
- France
- U.K.
- Italy
- Spain
- Sweden
- Netherlands
- Turkey
- Switzerland
- Belgium
- Rest of Europe
Asia-Pacific
- South Korea
- Japan
- China
- India
- Australia
- Philippines
- Singapore
- Malaysia
- Thailand
- Indonesia
- Rest of APAC
Latin America
- Mexico
- Colombia
- Brazil
- Argentina
- Peru
- Rest of South America
Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- South Africa
- Rest of MEA
Key Players
- QIAGEN
- Thermo Fisher Scientific
- Siemens
- Danaher
- Myriad Genetics Inc.
- Illumina Inc.
- Agilent Technologies Inc.
- BD
- Grifols S.A.
- Genetic Signatures
- TBG Diagnostics Limited
- GenMark Diagnostics Inc.
- Exact Sciences Corporation
- Abbott
- Roche Diagnostics
- Novartis
- Becton Dickinson
- Hologic Inc.
- bioMérieux
- others
+44-1173181773
sales@brandessenceresearch.com
We are always looking to hire talented individuals with equal and extraordinary proportions of industry expertise, problem solving ability and inclination interested? please email us hr@brandessenceresearch.com
JOIN USFIND ASSISTANCE
LONDON OFFICE
BrandEssence® Market Research and Consulting Pvt ltd.
124, City Road, London EC1V 2NX
FOLLOW US
© Copyright 2024-25 BrandEssence® Market Research and Consulting Pvt ltd. All Rights Reserved | Designed by BrandEssence®
